Global Biopolitics Research Group Working paper 35 A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA. Stuart Hogarth Department of Political Economy, King’s College London Michael Hopkins SPRU, University of Sussex King’s College London Strand London WC2R 2LS